Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 AUD | +4.92% | +3.23% | -9.86% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-9.86% | 11.6M | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-18.90% | 29.48B | |
+57.86% | 25.43B | |
-17.68% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm : Achieves Full Enrolment for Part Two of NOXCOVID Trial; Shares Fall 3%